Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Applied Genetic Technologies (AGTC)
NASDAQ:AGTC
Applied Genetic Technologies (AGTC) Stock Price & Analysis
0 Followers
AGTC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range― - ―
Previous Close$0.39
Volume66.25K
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding67,632,195
10 Day Avg. Volume1,246,396
30 Day Avg. Volume1,966,600
Standard Deviation0.24
R-Squared0.11
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)1.51
Price to Sales (P/S)81.91
Price to Cash Flow (P/CF)1.80
P/FCF Ratio-0.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$0.36Price Target Upside-10.00% Downside
Rating ConsensusHold
Number of Analyst Covering6
Applied Genetic Technologies News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AGTC FAQ
What was Applied Genetic Technologies’s price range in the past 12 months?
Currently, no data Available
What is Applied Genetic Technologies’s market cap?
Currently, no data Available
When is Applied Genetic Technologies’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Applied Genetic Technologies’s earnings last quarter?
Currently, no data Available
Is Applied Genetic Technologies overvalued?
According to Wall Street analysts Applied Genetic Technologies’s price is currently Overvalued.
Does Applied Genetic Technologies pay dividends?
Applied Genetic Technologies does not currently pay dividends.
What is Applied Genetic Technologies’s EPS estimate?
Applied Genetic Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Applied Genetic Technologies have?
Currently, no data Available
What happened to Applied Genetic Technologies’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Applied Genetic Technologies?
Currently, no hedge funds are holding shares in AGTC
---
Applied Genetic Technologies Stock Smart Score
Company Description
Applied Genetic Technologies
Applied Genetic Technologies Corp. engages in the development of gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. It has clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL.
---
Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.
---